Criptomonedas
Intercambios
Productos
0.0002711 BTC4.51%
0.008595 ETH5.09%
How do you feel about Injective Protocol today?
Vote to see community results
The Injective Protocol project is a revolutionary idea that aims to make currency exchanges completely decentralized, public operated networks. What this means is the exchange is solely operated by people who hold INJ tokens. There is no centralized governing body that enforces control over the development of the project. The Injective Protocol project officially launched via a public offering in 2020, and it was backed by names in the industry like Binance, Pantera and Hashed.
The Injective Chain is the blockchain foundation of the project. It hosts a completely decentralized order book and employs elements from the Ethereum Virtual Machine (EVM). The platform also incorporates a bi-directional token bridge, linking it to the Ethereum ecosystem.
Eric Chen is the co-founder of Injective Labs, the company behind INJ. He has a bachelor of science in finance from NYU Stern, and his professional career started back in 2014. Chen was a research fellow at Desay Sv Automotive, and later moved to AXA Advisors to become an analyst. In 2017, Eric Chen became a researcher for Innovating Capital, and a year later, in 2018, he co-founded Injective Protocol.
Albert Chon is the chief technical officer of Injective Protocol. He graduated with a computer science masters degree from Stanford University and became a full stack engineer for Linc Global in 2017. At the beginning of 2018, he started a position at Amazon as a software development engineer; however, he soon moved on to co-found Injective Protocol with Eric Chen. He has been with the company since its launch in mid-2018.
Injective Protocol is a noteworthy project because it aims to solve problems in the financial world by employing blockchain technology’s decentralized nature. INJ allows investors to participate in a genuinely decentralized finance (DeFi) organization, where they have the power to make changes happen and introduce new ideas.
The Injective Chain blockchain is available for anyone to use, which is what makes it completely decentralized. It does not matter if you are a small-time investor or a big-time corporation; Injective Protocol offers the same level of influence and power to everyone. The blockchain allows you to trade a vast array of derivatives, CFDs and other forms of assets.
While it introduces revolutionary technology to decentralize the world of exchanges and trading, Injective Protocol still operates on proven methods to make money. Makers and takers pay transaction fees in INJ, which allows the platform to continue working in a decentralized manner.
Learn more about Solana.
Check out Decred.
Read more about Decentralization.
Have a look at the CoinMarketCap blog.
The total supply of Injective Protocol (INJ) tokens is 100,000,000. Currently, there are about 15,406,012 INJ tokens in circulation on the market. According to the official INJ white paper, there is necessary inflation set to 7% at the launch of INJ tokens so that nodes are incentivized to validate transactions on the blockchain. This inflation rate is gradually going to decrease over time and reach 2%.
The way INJ tokens are distributed is based on aggregate profit-and-loss. In essence, the more INJ tokens you hold, the more you will receive when redistributions occur, as your wallet has a more significant weighted value. This ensures the decentralized nature of the exchange.
The Injective Protocol blockchain operates on a proof-of-stake (PoS) consensus mechanism. This is one of the more prominent similarities INJ has with the Ethereum blockchain. To use the mechanism of the Ethereum Virtual Machine, INJ relies on PoS for security.
Proof-of-stake is an alternative consensus to the popular proof-of-work (PoW) consensus used by Bitcoin. PoS has numerous advantages in terms of required power input for mining, scalability and usability. The consensus also plays an essential role in ensuring the decentralized manner of operation for the whole network.
Injective Protocol (INJ) tokens are available on most major exchanges. Binance has the highest INJ/USD trading volume at $12,687,084. This is the most popular exchange for purchasing INJ.
Other good options include Bilaxy, Huobi Global and Uniswap. It is important to note that buying cryptocurrency comes with risk, just like traditional investing.
Learn more about buying crypto with us.
Precio de Injective Protocol | $12.60 |
---|---|
Cambio o vuelto de precio24h | $0.8206 6.97% |
Mínimo en 24h / Máximo en 24h | $11.82 / $13.44 |
Volumen de Comercio24h | $33,916,510.81 21.76% |
Dominio del mercado | Sin datos |
Nivel de mercado | #131 |
Cap. de Mercado | $196,358,852.78 6.97% |
---|---|
Capitalización de mercado totalmente diluida | $1,260,289,763.01 6.97% |
# | Fuente | Pares | Precio | Volumen | Volumen % | Liquidez | Confianza | Actualizado |
---|---|---|---|---|---|---|---|---|
1 | ![]() Binance | $12.59 | $6,968,775 | 20.55% | 170 | High | Reciente | |
2 | ![]() Bilaxy | *** $12.68 | *** $3,820,310 | 0.00% | 66 | High | Reciente | |
3 | ![]() Binance | $12.59 | $2,258,194 | 6.66% | 129 | High | Reciente | |
4 | ![]() Binance | *** $12.67 | *** $942,967 | 0.00% | 106 | High | Reciente | |
5 | ![]() Huobi Global | $12.65 | $862,619 | 2.54% | 101 | High | Reciente | |
6 | ![]() Uniswap (V2) | $12.60 | $812,255 | 2.39% | - | High | Reciente |
* Precio excluido
** Volumen excluido
***Precio/Volumen excluido – Se detectó un valor atípico
The Injective Protocol project is a revolutionary idea that aims to make currency exchanges completely decentralized, public operated networks. What this means is the exchange is solely operated by people who hold INJ tokens. There is no centralized governing body that enforces control over the development of the project. The Injective Protocol project officially launched via a public offering in 2020, and it was backed by names in the industry like Binance, Pantera and Hashed.
The Injective Chain is the blockchain foundation of the project. It hosts a completely decentralized order book and employs elements from the Ethereum Virtual Machine (EVM). The platform also incorporates a bi-directional token bridge, linking it to the Ethereum ecosystem.
Eric Chen is the co-founder of Injective Labs, the company behind INJ. He has a bachelor of science in finance from NYU Stern, and his professional career started back in 2014. Chen was a research fellow at Desay Sv Automotive, and later moved to AXA Advisors to become an analyst. In 2017, Eric Chen became a researcher for Innovating Capital, and a year later, in 2018, he co-founded Injective Protocol.
Albert Chon is the chief technical officer of Injective Protocol. He graduated with a computer science masters degree from Stanford University and became a full stack engineer for Linc Global in 2017. At the beginning of 2018, he started a position at Amazon as a software development engineer; however, he soon moved on to co-found Injective Protocol with Eric Chen. He has been with the company since its launch in mid-2018.
Injective Protocol is a noteworthy project because it aims to solve problems in the financial world by employing blockchain technology’s decentralized nature. INJ allows investors to participate in a genuinely decentralized finance (DeFi) organization, where they have the power to make changes happen and introduce new ideas.
The Injective Chain blockchain is available for anyone to use, which is what makes it completely decentralized. It does not matter if you are a small-time investor or a big-time corporation; Injective Protocol offers the same level of influence and power to everyone. The blockchain allows you to trade a vast array of derivatives, CFDs and other forms of assets.
While it introduces revolutionary technology to decentralize the world of exchanges and trading, Injective Protocol still operates on proven methods to make money. Makers and takers pay transaction fees in INJ, which allows the platform to continue working in a decentralized manner.
Learn more about Solana.
Check out Decred.
Read more about Decentralization.
Have a look at the CoinMarketCap blog.
The total supply of Injective Protocol (INJ) tokens is 100,000,000. Currently, there are about 15,406,012 INJ tokens in circulation on the market. According to the official INJ white paper, there is necessary inflation set to 7% at the launch of INJ tokens so that nodes are incentivized to validate transactions on the blockchain. This inflation rate is gradually going to decrease over time and reach 2%.
The way INJ tokens are distributed is based on aggregate profit-and-loss. In essence, the more INJ tokens you hold, the more you will receive when redistributions occur, as your wallet has a more significant weighted value. This ensures the decentralized nature of the exchange.
The Injective Protocol blockchain operates on a proof-of-stake (PoS) consensus mechanism. This is one of the more prominent similarities INJ has with the Ethereum blockchain. To use the mechanism of the Ethereum Virtual Machine, INJ relies on PoS for security.
Proof-of-stake is an alternative consensus to the popular proof-of-work (PoW) consensus used by Bitcoin. PoS has numerous advantages in terms of required power input for mining, scalability and usability. The consensus also plays an essential role in ensuring the decentralized manner of operation for the whole network.
Injective Protocol (INJ) tokens are available on most major exchanges. Binance has the highest INJ/USD trading volume at $12,687,084. This is the most popular exchange for purchasing INJ.
Other good options include Bilaxy, Huobi Global and Uniswap. It is important to note that buying cryptocurrency comes with risk, just like traditional investing.
Learn more about buying crypto with us.
How do you feel about Injective Protocol today?
Vote to see community results